This page shows the latest Regeneron news and features for those working in and with pharma, biotech and healthcare.
With its antiviral candidates, Pfizer is now aiming to enter the COVID-19 therapeutic space, where Regeneron and Eli Lilly have largely dominated so far. ... Regeneron’s antibody cocktail ( casirivimab and imdevimab) has been granted an emergency use
Roche and Regeneron’s COVID-19 antibody cocktail has demonstrated positive results in a phase 3 trial assessing the investigational treatment in infected non-hospitalised patients. ... Regeneron, the company that has commercialisation responsibilities
Sanofi and Regeneron plan to submit their PD-1 inhibitor Libtayo to regulatory authorities this year for the treatment of advanced cervical cancer, after stopping a phase 3 trial early on ... Sanofi and Regeneron said in a statement that, based on the
Following this, the IDMC has recommended halting enrolment into the placebo group, which Regeneron said it will do ‘immediately’. ... In January, Regeneron announced that the antibody cocktail can be used as a passive vaccine to prevent COVID-19 in
New approval will see Libtayo compete with blockbuster immunotherapy Keytruda. Sanofi and Regeneron’s PD-1 inhibitor Libtayo has received US Food and Drug Administration (FDA) approval in first-line, advanced ... advanced non-small cell lung cancer,”
The FDA also granted Regeneron’s antibody cocktail REGN-COV2 an EUA in November 2020, for the treatment of mild-to-moderate COVID-19 patients who are at high risk of ... Regeneron’s EUA is based on data from the first 799 adults in an ongoing trial
More from news
Approximately 77 fully matching, plus 172 partially matching documents found.
The same approach may work against SARSCoV-2. Regeneron Pharmaceuticals, leveraging a platform that spawned an Ebola treatment, is leading efforts to show that antibodies can neutralise SARS-CoV-2. ... A clinical trial of Regeneron’s drug is scheduled
Evaluating IL-6 inhibitors: Roche’s Actemra and Sanofi and Regeneron’s Kevzara. Roche, Sanofi and Regeneron are also looking to repurpose their existing treatments and are currently testing their ... 19,” said George D Yancopoulos, co-founder,
The changes also mean Sanofi has downgraded some long-standing relationship in R&D – such as a fruitful tie-up with Regeneron that generated some of its top-selling drugs like ... Analysts think the deal could catapult Galapagos into the top tier of
Client:Sanofi Genzyme and Regeneron. Agency:Havas Lynx Group. Campaign:See Below. Timescale:N/A. Atopic dermatitis affects approximately 1-3% of adults worldwide. ... Topical corticosteroids are commonly used to treat atopic dermatitis. Sanofi Genzyme
Innovation in Healthcare Communications. One high profile winning campaign was Havas Lynx Group’s ‘See Below’ on behalf of Sanofi Genzyme and Regeneron.
More from intelligence
Approximately 1 fully matching, plus 19 partially matching documents found.
Prior to this, Dr Evans held a number of scientific leadership positions while at Amgen, Johnson &Johnson and Regeneron.
Robert Landry succeeds Murray Goldberg. Former Pfizer senior VP Robert Landry has joined Regeneron as senior VP, finance, and will later take over as chief financial officer. ... We are extremely fortunate that Murray will stay at Regeneron through 2014
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
In the latest episode of Impetus Digital's Fireside Chat, I talk with Sandra Graham-Mason, Director of Marketing at Regeneron Pharmaceuticals.
Shire/Takeda. Pfizer. Amgen. Regeneron.
Leo. Mead Johnson Nutrition. Mundipharma. Novartis. Pfizer. Regeneron.
More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.
AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...